Objective: To present a comprehensive review of current and historical literature on scleral lenses. Methods: A comprehensive search of several databases from each database's earliest inception to May 23, 2014 was conducted by an experienced librarian with input from the author to locate articles related to scleral lens design, fabrication, prescription, and management. Results: A total of 899 references were identified, 184 of which were directly related to scleral lenses. References of interest were organized by date, topic, and study design. Most of articles published before 1983 presented lens design and fabrication techniques or indications for scleral lens therapy. Case reviews published after 1983 identified major indications for scleral lenses (corneal ectasia, ocular surface disease, and refractive error) and visual and functional outcomes of scleral lens wear. Statistically significant improvements in visual acuity, vision-related quality of life, and ocular surface integrity were reported. Reviews of ocular and systemic conditions suggested that comprehensive management strategies for these conditions could include scleral lenses. Early work investigating scleral lens fitting characteristics, optical qualities, and potential physiological impact on anterior ocular structures have been published in the past 5 years. Conclusions: Indications for scleral lens wear are well-established. Developing areas of research on the physiologic impact of scleral lens wear on the ocular surface, the use of technology to improve scleral lens vision and fit, and the impact of these devices on the quality of life should further enhance our understanding of scleral lenses in the future.
T he earliest descriptions of contact lenses appeared in medical literature in the late 1800s. English translations of these early works by Mueller, Fick, and Kalt were published in the 1980s. [1] [2] [3] Early "scleral shells" ranged from 19 to 21 mm in diameter, and were made of blown or ground glass. 4 These devices did not achieve widespread acceptance because of the corneal hypoxia that they induced and challenges of lens manufacturing. The development of impression molding techniques and materials in the 1930s led to an increase in interest in scleral contact lenses, both for management of ocular disease 5, 6 and for correction of refractive error. 7 That interest waned in the mid-1900s, however, because other contact lens designs became more widely available in both polymethylmethacrylate (PMMA) and hydrogel materials. Although scleral lenses were largely supplanted by these newer corneal contact lens designs and hydrogel lenses, they continued to be prescribed as therapeutic devices during the ensuing decades. [8] [9] [10] [11] [12] [13] [14] [15] [16] In 1983, Ezekiel 17 published the first description of scleral lenses made from rigid gas-permeable (RGP) materials. The use of these new materials reduced the risk of hypoxic complications with scleral lens wear; nonetheless, few contact lens manufacturers offered RGP scleral lens designs through the 1980s and early 1990s. One of the initial impediments to widespread adoption of RGP scleral lenses was a lack of commercial availability of largediameter lens buttons of RGP materials. Technological limitations, in corneal imaging systems and contact lens lathes available at the time, also challenged early scleral lens design and development.
Availability of RGP scleral lenses has now expanded dramatically. A recent search of scleral lens designs included on the Gas Permeable Lens Institute's website yielded a list of 17 manufacturers currently offering 41 different scleral lens designs (http:// apps.gpli.info/asp/search.aspx, Accessed May 26, 2014) . A few RGP materials, including Boston XO, XO2, and Equalens II (Bausch and Lomb, Rochester, NY), Optimum Extra (Contamac, Grand Junction, CO), Tyro-97 (Lagado Corporation, Engelwood, CO), and Paragon HDS (Paragon Vision Sciences, Mesa, AZ), are now available in large-diameter buttons. Improvements in our ability to assess the contour of the entire corneal surface facilitate the design of large-diameter lenses. Computer-driven lathes can now accurately produce large-diameter lenses to precise specifications. The development and wide availability of diagnostic fitting lens sets has improved access to scleral lens therapy, allowing eye care providers outside of highly specialized tertiary care centers to use these devices in the care of their patients.
The explosion of interest in scleral lenses over the past several years has led to some confusion regarding terminology used to describe the devices. Technically, any contact lens that extends beyond the limbus could be considered a "scleral" lens. In fact, the use of a silicone hydrogel "mini-scleral" lens after corneal crosslinking has been reported. 18 However, general consensus in the eye care community is that scleral lenses are fabricated from rigid, rather than hydrogel, materials. Several diameter-based classification systems have been proposed. 19, 20 Unfortunately, classification based on lens diameter alone does not fully convey the unique fitting characteristics of these devices. Classification based on these characteristics may allow for more precise definition of these devices and has been described by several authors. 21, 22 In June 2013, the Scleral Lens Education Society proposed standard nomenclature based on fitting characteristics (https://www.sclerallens.org, Accessed July 24, 2014) . Under this classification system, lenses that rest entirely on the cornea are considered corneal lenses. Lenses that rest on both corneal and scleral tissue are classified as corneo-scleral lenses. Scleral lenses are defined as RGP devices that are supported entirely by the conjunctival tissue overlying the sclera, and vault the cornea and limbus. Further distinctions within the category of scleral lenses define mini-sclerals as lenses up to 6 mm larger than the horizontal visible iris diameter (HVID) and full sclerals as lenses more than 6 mm larger than the HVID. This study will define scleral lenses according to the Scleral Lens Education Society's recommended nomenclature.
Expanding interest in clinical applications for scleral lenses has been accompanied by the development of a body of literature related to the devices. This review will provide a summary of this literature, and will offer perspective on the development, prescription, management, and impact of scleral lenses on the eye and on patients who wear them.
METHODS
A comprehensive search of several databases from each database's earliest inception to May 23, 2014, 
RESULTS
A list of 899 references was retrieved. Review of these references revealed a significant number of references on unrelated topics. Common topics of unrelated references retrieved by this search included intraocular lens designs, surgical techniques for crystalline lens extraction, and scleral pathology and surgery. The principal investigator reviewed each reference to determine its applicability to the topic of scleral lenses. One hundred eighty-four references related to the topic of interest were identified and reviewed in detail. Figure 1 shows distribution of the number of references published in each decade from 1940 to the present.
Early Scleral Lenses
Of the 184 references of interest, 45 were published before the introduction of RGP lenses in 1983. These articles originated from five different countries on three continents. In the United States alone, 11 different practices, including both private offices [23] [24] [25] [26] [27] and academic medical centers [28] [29] [30] [31] contributed to this literature. Most of these articles were descriptive reviews on a variety of topics, including anterior segment contour, 32, 33 specific lens designs, 6, 8, [34] [35] [36] methods of lens fabrication, 26, [29] [30] [31] [37] [38] [39] [40] [41] [42] indications, 6, 13, 28, 29, 31, 39, [42] [43] [44] comparisons between lenses of various designs, 14, 25, [45] [46] [47] the history of scleral lenses, 23, 48 and potential complications of lens wear. 24 During this time, several distinct lens designs were defined. 39 Molded, flush-fitting scleral shells, originally described by Ridley in 1962, 6 were the most commonly described design during this period. These lenses were created by obtaining an impression mold of the ocular surface, creating a plaster cast of the eye, and then molding a PMMA lens or shell to the plaster cast. The lens was then hand-polished, and the back surface was manually altered as needed to provide appropriate alignment with the anterior ocular surface. These devices were designed to minimally clear the surface of the cornea and to match any irregularities in surface contour. Given this requirement, optical correction could only be achieved through manipulation of the curvature of the front surface of the lens. These devices were generally prescribed for therapeutic purposes rather than optical correction. The term "scleral lens" was used to describe devices that rested entirely on the sclera and measurably vaulted the cornea. These lenses could provide relatively accurate optical correction and were fit either by impression molding or through the use of a set of diagnostic lenses. In all probability, these lenses more closely resembled the devices that we refer to as "scleral lenses" today.
Several case reports or case series were published during this period. 5, 6, [8] [9] [10] [11] 27, 34, 49 Indications for lens wear presented in these case series included management of severe ocular surface disease, 5, 8, 9, 11, 27, 49 corneal irregularity or ectasia, 6,10 and correction of ametropia. 6 Reported success rates ranged from 50% 9 to 100% 8 for various indications, with approximately 70% to 80% of patients achieving successful lens wear overall.
Prospective studies published before 1983 examined various lens fitting parameters and the physiologic effects of scleral lens or flush-fitting shell wear on the anterior ocular surface. In 1967, Miller et al. 50 compared corneal keratometry readings with measurements of the curvature of the corneal surface of the mold and concluded that the process of impression molding does not significantly deform the cornea. Miller and Carroll 51 also found that scleral lens wear seemed to result in an increase of corneal thickness that peaked approximately 3 weeks after initiation of lens wear and returned to baseline by the fourth week of wear. Tear exchange beneath a nonfenestrated scleral lens was evaluated using fluorophotometry by Miller and Carroll 51 and Ko et al. 52 Using an apparatus that consisted of a suction cup attached by wire to a spring gram gauge, Miller et al. 53 estimated that a wellfit scleral lens generated approximately 25 g of surface tension and further postulated that the actual negative pressure between the lens and the eye was between 5 and 18 mm Hg.
Rigid Gas-Permeable Scleral Lenses
The remaining 139 articles have been published between 1983 and the present. Approximately half of these articles (70) are either case reports or retrospective case series that describe the use of RGP scleral lenses. The rest of these studies are reviews of ocular or systemic conditions for which scleral lenses are prescribed, abstracts, prospective observational or interventional studies, retrospective observational studies, and descriptions of various lens designs. Studies originate from 14 countries on 5 continents. In the United States alone, over a dozen clinics and medical centers are represented. Eight different lens designs are identified by name in this body of literature and are summarized in Table 1 .
Case Reports/Retrospective Case Series
The case reports, case series, and retrospective reviews included in this study varied widely in format, information reported, and level of detail. This body of work identified indications for scleral lens treatment and reported a variety of outcome measures such as visual acuity, improvements in ocular comfort or quality of life as measured by validated instruments such as the Visual Function Questionnaire (VFQ 25) and Ocular Surface Disease Index (OSDI), and resolution of epithelial defects. The fitting process was described by several authors. Complications associated with scleral lens wear were also reported. Most of these publications reported either single cases or small case series. However, 13 retrospective case reviews of 50 or more patients have been published since 2004. Results of these recent larger studies are summarized in Table 2 .
Indications. Case reports, small case series, and large retrospective reviews identified primary indications for scleral lens wear. Indications were similar to those reported by earlier authors: treatment of ocular surface disease, visual rehabilitation for patients with corneal irregularity, and correction of refractive error. Commonly reported indications for scleral lens therapy are summarized in Table 3 .
Unique scleral lens applications were reported in some of these publications. Reeder 95 recently reported the use of RoseK2 IC lenses as scleral lenses in several patients with microophthalmia. Utilization of a scleral lens with an occlusive piggyback hydrogel lens for management of amblyopia in an infant with familial dysautonomia has been described. 124 The attachment of "ptosis props" to the anterior scleral lens surface has been used to manage blepharospasm. 125 Scleral lenses have been used to protect the ocular surface during treatment for head and neck malignancy 75 and staged eyelid reconstructive surgery 90 and to deliver medication to the ocular surface. 76, 82 Reduction of corneal scarring due to vascularized limbal keratitis with long-term wear of a scleral lens has been reported, 81 as has maintenance of corneal surface integrity after discontinuation of scleral lens treatment for limbal stem-cell deficiency. 61 These cases demonstrate the wide variety of ocular surface conditions that can be effectively treated with scleral lenses.
Outcome Measures. Improvements in visual acuity were reported in patients wearing scleral lenses for all indications. Some studies reported statistically significant improvements between prelens and postlens logMAR acuity. 63, 67, 79, 80, 87, 91, 93, 99, 100, 118, 126 Other studies reported the number of patients who experienced an improvement of at least two lines of Snellen acuity. 83, 103, 111 Still others report the percentage of patients who reach a given level of Snellen acuity. 62, 82, 126 Salam et al. 120 compared visual acuity with corneal RGP's to acuity with scleral lenses and found that scleral lenses provided vision that was at least comparable to their smaller counterparts.
In addition to improvements in visual acuity, improvements in ocular comfort or vision-related quality of life have also been reported with scleral lens wear. Statistically significant increases in VFQ 25 scores after scleral lens wear indicated improvements in overall visual function in several studies. 80, 97, 127 Decreased OSDI scores suggested that scleral lens wear may significantly improve ocular comfort. 87, 93, 97 Schornack et al. 21 Schornack and Baratz 59 Schornack and Patel 60 Schornack 61 Pecego et al. 62 Schornack et al. 63 MSD (Blanchard Contact Lens, Manchester, NH)
Dalton and Sorbara 64 Harthan 65 ProCornea (Eerbeek, the Netherlands) Visser et al. 66 Visser et al. 67, 68 PROSE (Boston Foundation for Sight, Needham, MA)
Cotter and Rosenthal 69 Rosenthal et al. 70 Rosenthal and Cotter 71 Rosenthal and Croteau 72 Jacobs and Rosenthal 73 Gungor et al. 74 Lin et al. 75 Lim et al. 76 Grover et al. 77 Gumus et al. 78 Rathi et al. 79 Baran et al. 80 Cressey et al. 81 Kalwerisky et al. 82 Rathi et al. 83, 84 Dimit et al. 85 Gire et al. 86 Lee et al. 87 Lim et al. 88 Ling et al. 89 Samimi et al. 90 Arumugan et al. 91 Ciralsky et al. 92 Heur et al. 93 Mahadevan et al. 94 Rose K (Blanchard Contact Lens, Manchester, NH)
Reeder 95 Rose and Choo 96 SPOT; LAO (Thonon Les Baines, France) Tougeron-Brousseau et al. 97 a Additional lens designs have been described but not specifically identified by name, and have therefore not been included in this summary.
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Other studies reported decreased photophobia and increased ocular comfort using less formal questionnaires. 73, 103, 126 Wearing time has also been proposed as a measure of success in scleral lens wear. 100 Up to 16 to 18 hr of comfortable wear daily has been reported. 99, 102, 111 Of interest, a few studies reported that many patients wearing both PMMA and RGP lenses need to remove the lenses after several hours of wear, 55, 68, 72, 79, 102, 103, 111, 128 patients who periodically removed, rinsed, refilled, and reapplied lenses periodically during the day were statistically more likely to be more successful with scleral lens wear than those who did not. 100 Scleral lens fitting and subsequent wear require a considerable investment in time, energy, effort, and money. A unique costbenefit analysis of the Boston Ocular Surface Prosthesis was performed in 2009, and it reported favorable benefit-cost ratio in patients with severely compromised vision or visual function due to corneal irregularity or ocular surface disease. 129 Fitting Process. Several studies have reported the number of lenses and visits needed to complete the fitting process as an indication of the complexity of scleral lens fitting. 21, 60, 62, 118 Schornack 21, 60, 63 found that fitting could be completed in an average of approximately three visits, and that the process usually requires no more than two lenses per eye. In contrast, Pecego et al. 62 reported that the fitting process required an average of 6.2 visits and 3.2 lenses per eye.
To further elucidate the complexity of the fitting process, Rose and Choo taught 17 individuals with experience fitting corneal RGP's only a 5-step system for fitting scleral lenses. The new scleral lens fitters then attempted to fit 120 eyes with scleral lenses. Their success rate was over 75%. 96 Several case reports include detailed descriptions of scleral lens fitting. 64, 94 These studies provide insight into the effects of various modifications of lens design on the physical relationship between the posterior lens and anterior ocular surface.
Lens Designs. With the exception of a single retrospective review that included patients who were originally fit with scleral lenses until 30 years ago, 98 all of the studies published within the past 10 years used preformed diagnostic fitting sets for initial evaluation. Based on the fit observed with a diagnostic lens, lens parameters were customized as necessary to provide appropriate haptic alignment and corneal clearance. Haptic customization was accomplished through changes in peripheral curve radius or diameter or the use of toric or region-specific flange modifications, 63, 66 and corneal chamber modifications were accomplished either through the use of spline-control vault adjustment 72 or manipulation of radius of curvature and diameter of peripheral curves. 63 Customization of lens design to allow for scleral lens wear in patients who have undergone filtering procedures for glaucoma has been described. 130 In his recent review, van der Worp et al. 22 referred to a recent development in scleral lens fabrication; as was the case in the early 1900s, scleral devices can once again be fabricated based on an impression mold of the ocular surface.
Complications. Despite the fact that much of the literature reviewed described the therapeutic use of scleral lenses in management of significant ocular disease, a limited number of complications have been reported. Individual case reports described microbial keratitis, 123, 131 Acanthamoeba keratitis, 132 and nonulcerative keratitis 133 associated with scleral lens wear. Several larger reviews also reported isolated complications. 63, 70, 72 The incidence of microbial keratitis associated with scleral lens wear has not been definitively determined, but 2 studies have reported incidence rates of 0.5% 63 and 1.6%. 72 Given the severity of ocular surface disease described in these studies, it is difficult to determine whether the complication was truly a result of scleral lens wear or simply a manifestation of the underlying disease.
Reviews
Thirty-seven reviews were retrieved in our literature search. These articles included several documents that described the historical development or fabrication of scleral lenses, [1] [2] [3] 134, 135 as well as several articles that specifically describe particular lens designs or indications for use. Rosenthal and Cotter 71 der Worp et al. 22 published a review of scleral lens designs, fitting approaches, indications, and potential adverse events associated with scleral lens wear. Scleral lenses were mentioned in general reviews of several ocular conditions, including pellucid marginal corneal degeneration, 137 keratoconus, [138] [139] [140] [141] and dysfunctional tear syndrome. 142 Reviews of contact lens management for keratoconus, 143, 144 kera-toconus and penetrating keratoplasty, 141 post-laser in situ keratomileusis patients, 145 corneal disease, 146 and persistent epithelial defects 147 included scleral lenses among available therapeutic options. The devices are also mentioned in reviews of several medical or systemic conditions, including facial nerve palsy, 148 ocular cicatricial pemphigoid, 149, 150 chronic graft vs. host disease, [151] [152] [153] [154] [155] and Stevens-Johnson Syndrome. 156 
Observational and Interventional Studies
Several authors have evaluated characteristics of lens fit in successful scleral lens wearers in attempts to objectively define fitting relationships. Schornack and Patel 157 compared topographic indices with scleral lens base curve in patients with keratoconus and ocular surface disease. Although steep K, flat K, and reference sphere were correlated with base curve in both conditions, the relationship was not found to be predictive. Sonsino and Mathe 158 used anterior segment ocular surface tomography (OCT) to measure central corneal vault in 20 eyes of 12 patients wearing scleral lenses for management of keratoconjunctivitis sicca because of graft versus host disease. He reported a mean vault of 3806110 mm and concluded that distance between the posterior surface of the lens and the anterior corneal surface can vary widely in successful scleral lens wear.
In addition to allowing for precise measurement of anterior segment parameters, anterior segment OCT may eventually be used to design scleral lenses that more closely approximate the contour of the ocular surface. This technology has already been used to visualize contact lens to cornea relationships 159 and has improved our understanding of scleral contour. 22 Several authors have already begun to apply anterior segment OCT to the scleral lens design process. [160] [161] [162] Although both corneal and scleral RGP lenses provide a smooth prosthetic ocular surface, visual acuity with rigid lenses may be disappointing in patients with corneal irregularity because of higher order aberrations (HOA). 163 Adjusting front surface asphericity 164 or eccentricity 119 may improve visual performance. However, wavefront aberrometers can now precisely quantify HOA within an optical system. Gumus et al. 122 found that scleral lenses significantly reduce HOA compared with correction with spectacles or hydrogel contact lenses but provide less dramatic reduction when compared with corneal RGP lenses. Gemoules and Morris 165 described significant reductions in HOA with a unique large-diameter RGP lens design in postrefractive surgery patients. Rotational and translational stability of scleral lenses may provide an ideal platform for optical compensation for HOA. Several researchers have attempted to incorporate HOA correction into scleral lenses for patients with keratoconus. 166, 167 Although both were successful in reducing the severity of HOA, visual acuity did not reach normal levels in either study.
The physiological impact of scleral lenses on the anterior segment is yet to be rigorously studied. Several authors have raised concerns regarding possible scleral lens-induced corneal hypoxia, based on mathematical models of oxygen transmissibility. 168, 169 Pullum and Stapleton 170 who evaluated corneal swelling (as a measure of hypoxic stress) with scleral lenses of various dK levels found that corneal swelling was inversely related to dK, but that the relationship was not linear. Mean corneal swelling was less than 3% after 3 hr of wear of a lens with 0.6 mm center thickness and a dK of 115. In a separate study, Smith et al. 171 reported 4.9% 102 Romero-Rangel et al., 103 Rosenthal et al., 70 Tappin et al., 104 Rosenthal and Croteau, 72 Gungor et al., 74 Tougeron-Brousseau et al., 97 Rathi et al., 79 Alipour et al., 105 Rathi et al., 83 Arumugam et al., 91 Heur et al. 93 Chronic graft vs. host disease Rosenthal and Croteau, 72 Takahide et al., 106 Ye et al., 107 Schornack et al., 21 Pecego et al., 62 Alipour et al., 105 Jacobs et al., 108 Schornack et al. 63 
Exposure keratopathy
Schein et al., 109 Van Meter and Conklin, 110 Romero-Rangel et al., 103 Tappin et al., 104 Segal et al., 111 Williams and Aquavella, 112 Grey et al., 113 Gire et al., 86 Weyns et al., 114 Schornack et al. 63 
Neurotrophic keratopathy
Schein et al., 109 Alipour et al., 105 Schornack et al. 63 
Cicatrizing conjunctivitis
Foss et al., 102 Schornack and Baratz, 59 Schornack, 61 Schornack et al. 63 
Persistent epithelial defects
Pecego et al., 62 Lim et al., 88 Ling et al., 89 Ciralsky et al. 92 
Sjogren syndrome
Rosenthal and Croteau, 72 Pullum and Buckley, 115 Visser et al., 101 Dimit et al. 85 
Corneal dystrophy/ degeneration
Romero-Rangel et al., 103 Schornack, 116 Pecego et al., 62 Lee et al., 87 Schornack 63 Congenital corneal hypoanesthesia Schein et al., 109 Gungor et al., 74 Alipour et al. 105 Visual rehabilitation/corneal irregularity Primary corneal ectasia Foss et al., 102 Tan et al., 55, 56 Pullum and Buckley, 57 Vreugdenhil et al., 117 Segal et al., 111 Rosenthal and Croteau, 72 Tomalla and Cagnolati, 54 Gungor et al., 74 Schornack and Patel, 60 Dalton and Sorbar, 64 Baran et al., 80 Pecego et al., 62 Lee et al., 87 Ortenberg et al., 100 Romero-Jiminez and Flores-Rodriguez, 118 Visser et al., 101 Arumugam et al., 91 Jagadeesh and Mahadevan, 119 Mahadevan et al. 94 
S/P penetrating keratoplasty
Schein et al., 109 Tan et al., 55, 56 Pullum and Buckley, 57 Romero-Rangel et al., 103 Segal et al., 111 Pullum et al., 98 Rosenthal and Croteau, 72 Salam et al., 120 Visser et al., 67, 68 Pecego et al., 62 Ortenberg et al., 100 Visser et al., 101 Arumugam et al., 91 Severinsky et al. 99 
S/P refractive surgery
Segal et al., 111 Baran et al., 80 Pecego et al., 62 Lee et al., 87 Romero-Jiminez and Flores-Rodriguez, 118 Tse, 121 Arumugam et al. 91 
Corneal scarring
Gumus et al., 122 Alipour et al., 105 Pecego et al., 62 Lee et al., 87 Zimmerman and Marks 123 Correction of refractive error Aphakia Berkowitsch, 15 Schein et al., 109 Tan et al., 55, 56 Pullum and Buckley, 57 Gungor et al., 74 Pecego et al. 62 
High ametropia (nonaphakic)
Foss et al., 102 Tan et al., 55, 56 Pullum et al., 98 
DISCUSSION
Direct comparisons of study results and conclusions within this body of literature are difficult, given the lack of standardization inherent in retrospective work. A variety of lens designs were used. Patient characteristics (severity of disease, socioeconomic status, and geographic proximity to prescribing clinic) were not defined. In all probability, practice patterns at each clinical site (local, regional, or national referral patterns; protocols for collection of specific tests or information on scleral lens patients; recommendations for follow-up; instructions for lens care and wearing schedules; methods for reporting outcomes) vary widely. It is striking to note similarities between indications and favorable outcomes reported by different clinical practices, despite all of these variables. This consistency suggests that therapeutic effects can be achieved with a variety of lens designs in a variety of practice settings.
Comprehensive review of non-peer-reviewed literature was beyond the scope of this review, but a cursory search of the term "scleral lens" in the archives of Contact Lens Spectrum, a widely distributed monthly publication that focuses on developments in the contact lens industry, yielded 262 related articles and case reports dating back to 1994 (http://www.clspectrum.com/magazinearchive. aspx, Accessed May 26, 2014). Nearly 200 of these articles have been published since 2010. A perusal of this literature suggested that scleral lens prescription and management is no longer limited to highly specialized tertiary care centers, and that scleral lenses are increasingly being considered for correction of simple refractive error. Estimates of the number of patients who may be wearing scleral lenses for this purpose are not available, but lenses specifically designed for correction of simple refractive error are commercially available. However, the relatively high cost of scleral lenses and handling requirements (potentially including midday removal and reapplication necessitated by accumulation of debris in the postlens fluid reservoir or development of anterior lens surface deposits) may be limiting enthusiasm for this potential application.
As of yet, scleral lens-related literature provides little insight into the potential effects of these devices on anterior segment anatomy and physiology. Given differences in fitting characteristics between corneal, corneo-scleral, and scleral RGP's, as well as potential differences between miniscleral and full-scleral lenses, we cannot assume that all of these lens designs affect anterior segment of the eye in the same way. It would be advisable to fully explore potential metabolic and mechanical challenges to anterior segment structures before fully embracing the use of scleral lenses in healthy eyes. Lens and fluid reservoir thickness may present a significant barrier to oxygen transmissibility and may lead to hypoxic complications. Rate and volume of tear exchange beneath the lens is not yet known. Evidence-based guidelines for ideal lens fit characteristics and care products have yet to be developed. Neither the incidence of complications nor risk factors for complications with scleral lens wear have been identified. For patients with few other options for disease management, we can be reasonably confident that the risks of inaction or surgical intervention outweigh potential risks of scleral lens wear, but the exact placement of scleral lenses within an overall management strategy has yet to be defined. Despite unanswered questions regarding scleral lenses, these devices have demonstrated great potential to improve vision and quality of life in patients with a wide variety of ocular conditions. In the future, further improvements in lens design, increased availability of lenses, and better geographic distribution of eye care providers who offer scleral lens therapy will hopefully make it possible for more patients to experience the benefits of these devices.
